Early Experience with Dabrafenib–Trametinib Combination in Patients with BRAF-Mutated Malignant Melanoma—A Single-Center Experience
Background Combination of dabrafenib–trametinib is one of the standard treatments in patients with BRAF-mutated advanced malignant melanoma (MM). Real-world data on the usage of this combination is scarce, especially from India. Here, we are reporting our early experience with the usage of this comb...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/ca8a8c87174249fa9e9b1eb06129f6e3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|